Prolight’s CEO to BioStock: ”Proof-of-Performance in whole blood important milestone”

Report this content

Prolight Diagnostics has demonstrated Proof-of-Performance in whole blood for its digital test system Psyros. It is already known that the system performs as promised for measuring troponin in serum, as well as thyroid-stimulating hormone in blood plasma. The latest results show that the system has equivalent performance in whole blood. BioStock reached out to the company's CEO Ulf Bladin to find out more. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/prolights-ceo-proof-of-performance-in-whole-blood-important-milestone

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Subscribe

Documents & Links

Quick facts

Prolight’s CEO to BioStock: ”Proof-of-Performance in whole blood important milestone”
Tweet this